Clinical Trials Logo

Lower Resp Tract Infection clinical trials

View clinical trials related to Lower Resp Tract Infection.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04267822 Withdrawn - Clinical trials for Stem Cell Transplant Complications

Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV

REVIRAL2
Start date: June 15, 2020
Phase: Phase 2
Study type: Interventional

RV521 is to being developed to treat RSV infection and disease in susceptible individuals at high risk for complications. This is an international, multicenter, placebo-controlled study. Eligible subjects are adults with a documented symptomatic RSV infection who have undergone HCT transplantation and are moderately to severely immunocompromised. Qualified subjects will be randomized in a 1:1 ratio to receive RV521 or placebo, twice daily for 10 days.